Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02805257 · ClinicalTrials.gov registry record · Phase 2
Ahmed Glaucoma Valve Surgery With Mitomycin-C
A Phase 2 study of Glaucoma and Primary Open Angle Glaucoma, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 119
- Enrollment target
- 4
- Study locations
NCT02805257 is a Phase 2 study of Glaucoma and Primary Open Angle Glaucoma that has completed, run by University of California, San Francisco. The registered enrollment target is 119 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (87% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT02805257, a Phase 2 study of Glaucoma and Primary Open Angle Glaucoma, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 119 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
Conditions Studied
Interventions
- DRUG Mitomycin-C
- OTHER Balanced Salt Solution
- PROCEDURE Ahmed Glaucoma Valve Implant
Study Locations (4)
California
- University of California, San Francisco - San Francisco
Guangdong
- Zhongshan Ophthalmic Center - Guangzhou
Chhattisgarh
- Shri Ganesh Vinayak Eye Hospital - Raipur
Other
- Asociación para Evitar la Ceguera en México (APEC) - Mexico City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02805257
The ClinicalTrials.gov registry entry for NCT02805257 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (87% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Glaucoma appearing as the primary indexed condition, and to 3 interventions - of which Mitomycin-C is the first listed.
NCT02805257 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Guangdong, Chhattisgarh.
Frequently Asked Questions
What is clinical trial NCT02805257 about?
NCT02805257 is a clinical study titled "Ahmed Glaucoma Valve Surgery With Mitomycin-C". This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.
What is the current status of trial NCT02805257?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 119 participants. The study started on 2016-06. Estimated completion is 2020-03.
What conditions does trial NCT02805257 study?
This clinical trial studies the following conditions: Glaucoma, Primary Open Angle Glaucoma, Secondary Glaucoma, Neovascular Glaucoma.
What interventions are being tested in trial NCT02805257?
The interventions under investigation include: Mitomycin-C (DRUG), Balanced Salt Solution (OTHER), Ahmed Glaucoma Valve Implant (PROCEDURE).
Who is sponsoring clinical trial NCT02805257?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02805257 being conducted?
This trial has 4 study locations across California, Guangdong, Chhattisgarh. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
RECRUITING · Phase 2
-
Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
ACTIVE NOT RECRUITING · Phase 2
-
Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma
ACTIVE NOT RECRUITING · Phase 2
-
Circadian Rhythms of Aqueous Humor Dynamics in Humans
COMPLETED · Phase 2
-
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.